advertisement

Oculus

11.16 Vehicles, delivery systems, pharmacokinetics, formulation (92)

Showing records 1 to 25

Display all abstracts in classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation

Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation
92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Abdelmonem R
Pharmaceutics 2021; 13:
92071 New strategies for the management of ocular surface disease in glaucoma patients
Voicu L
Current Opinions in Ophthalmology 2021; 32: 134-140
92251 Latanoprost-loaded phytantriol cubosomes for the treatment of glaucoma
Bessone CDV
European Journal of Pharmaceutical Sciences 2021; 160: 105748
92109 Corneal epithelium and limbal region alterations due to glaucoma medications evaluated by anterior segment optic coherence tomography: a case-control study
Güçlü H
Cutaneous and Ocular Toxicology 2021; 40: 85-94
92121 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
Ansari E
Advances in Therapy 2021; 38: 2990-3002
92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Harasymowycz P
Advances in Therapy 2021; 38: 3019-3031
92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Tan C
Journal of materials chemistry. B 2021; 9: 3335-3345
92487 Comparison of the Intraocular Pressure-Lowering Effect and Safety of Preservative-Free And Preservative-Containing Brimonidine/Timolol Fixed-Combination Ophthalmic Solutions in Patients with Open-Angle Glaucoma
Kim JM
Seminars in Ophthalmology 2021; 36: 103-109
92043 Nanomedicines for the treatment of glaucoma: Current status and future perspectives
Zhai Z
Acta biomaterialia 2021; 125: 41-56
92288 Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma
Allam A
International Journal of Pharmaceutics 2021; 598: 120380
92066 Dry eye disease among Glaucoma patients on topical hypotensive medications, in a tertiary hospital, Ethiopia
Sahlu M
BMC Ophthalmology 2021; 21: 155
92224 Targeted delivery of LM22A-4 by cubosomes protects retinal ganglion cells in an experimental glaucoma model
Ding Y
Acta biomaterialia 2021; 126: 433-444
91911 Advances in medical therapy for glaucoma
Ostler E
Current Opinions in Ophthalmology 2021; 32: 129-133
92597 Optimization and Characterization of Brimonidine Tartrate Nanoparticles-loaded In Situ Gel for the Treatment of Glaucoma
Sharma PK
Current Eye Research 2021; 0: 1-14
92812 Pharmacokinetics and Pharmacology of Latanoprost 0.005% without Benzalkonium Chloride Vs Latanoprost 0.005% with Benzalkonium Chloride in New Zealand White Rabbits and Beagles
Halder A
Current Eye Research 2021; 46: 1031-1037
92528 Improved Treatment Options for Glaucoma with Brimonidine-Loaded Lipid DNA Nanoparticles
Schnichels S
ACS applied materials & interfaces 2021; 13: 9445-9456
92598 Real-World Study on Patient Satisfaction and Tolerability After Switching to Preservative-Free Latanoprost
Erb C
Clinical Ophthalmology 2021; 15: 931-938
92224 Targeted delivery of LM22A-4 by cubosomes protects retinal ganglion cells in an experimental glaucoma model
Chow SH
Acta biomaterialia 2021; 126: 433-444
92043 Nanomedicines for the treatment of glaucoma: Current status and future perspectives
Cheng Y
Acta biomaterialia 2021; 125: 41-56
92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Hutnik C
Advances in Therapy 2021; 38: 3019-3031
92487 Comparison of the Intraocular Pressure-Lowering Effect and Safety of Preservative-Free And Preservative-Containing Brimonidine/Timolol Fixed-Combination Ophthalmic Solutions in Patients with Open-Angle Glaucoma
Kim TW
Seminars in Ophthalmology 2021; 36: 103-109
92598 Real-World Study on Patient Satisfaction and Tolerability After Switching to Preservative-Free Latanoprost
Stalmans I
Clinical Ophthalmology 2021; 15: 931-938
92071 New strategies for the management of ocular surface disease in glaucoma patients
Salim S
Current Opinions in Ophthalmology 2021; 32: 134-140
92251 Latanoprost-loaded phytantriol cubosomes for the treatment of glaucoma
Akhlaghi SP
European Journal of Pharmaceutical Sciences 2021; 160: 105748
92597 Optimization and Characterization of Brimonidine Tartrate Nanoparticles-loaded In Situ Gel for the Treatment of Glaucoma
Chauhan MK
Current Eye Research 2021; 0: 1-14

Issue 22-1

Change Issue


advertisement

Oculus